Patents/Assignees

Novimmune SA

4 patents in portfolio

US12583922utility2026
Bispecific Antibodies Targeting CD47 and PD-L1 and Methods of Use Thereof
0 cites
US12448444utility2025
Bispecific Antibodies Targeting CD47 and PD-L1 and Methods of Use Thereof
0 cites
US11840553utility2023
Anti-cd47 Antibodies and Methods of Use Thereof
0 cites
US11827703utility2023
Compositions and Methods Related to Anti-cd19 Antibody Drug Conjugates
0 cites